The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a loss of -78.87%.However, over the last six months, we can see a stronger performance of -59.62%. Over the last 30 days, the price of EDIT has leaped by -34.76%. And in the last five days, it has fallen by -4.46%.
Editas Medicine Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $11.69 on 02/28/24, while the lowest price during the same period was $1.89 on 12/06/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of EDIT Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Editas Medicine Inc’s current trading price is -81.69% away from its 52-week high, while its distance from the 52-week low is 13.23%. The stock’s price range for this period has been between $1.89 and $11.69. The Healthcare sector company’s shares saw a trading volume of about 2.78 million for the day, which was higher than the average daily volume of 2.21 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Editas Medicine Inc (EDIT) has experienced a quarterly decline of -39.03% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 197.92M and boasts a workforce of 265 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.56, with a change in price of -3.58. Similarly, Editas Medicine Inc recorded 1,987,747 in trading volume during the last 100 days, posting a change of -62.59%.
EDIT’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for EDIT stands at 0.22. Similarly, the long-term debt-to-equity ratio is also 0.13.
EDIT Stock Stochastic Average
As of today, the raw stochastic average of Editas Medicine Inc over the past 50 days is 13.09%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 16.84%. Additionally, the Stochastic %K and %D values for the company were 6.98% and 3.81%, respectively, over the past 20 days.
